Product Code: 04-NIPT-ANEU-27
From £656.00
Deadline to order: 01/03/2027
NIPT for common aneuploidies (including sex chromosomes) (plasma).
NIPT for the 3 most common aneuploidies (Chr 13, 18 and 21), fetal sex and sex chromosome aneuploidies. An optional element will be included for the testing and reporting of fetal sex and sex chromosome aneuploidies (in recognition that this extension to testing is offered by many laboratories as part of their clinical service).
NIPT
English, French, German, Italian, Spanish
Plasma (cfDNA)
Yes
Oct-27
October - November 2027
March 2028
You can complete purchase on our secure partner site.
The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.
Two mock clinical cases with matching samples will be provided. Approximately 1ml of artificial plasma containing approximately 30ng DNA per sample is provided. Complete information will be available in the scheme instructions.
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results. Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Participants are expected to test samples according to their routine strategy and to return a clinical report.
No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).
This EQA is delivered in collaboration with GenQA.
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.
